HOME >> BIOLOGY >> NEWS
NIH holds conference to assess evidence on management of menopauserelated symptoms

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on Management of Menopause-Related Symptoms, March 21-23, 2005, at the Natcher Conference Center on the NIH campus in Bethesda, Maryland. The conference will bring together researchers and practitioners in various aspects of menopausal care and research to examine and synthesize the available scientific evidence on treatment of menopausal symptoms. A press briefing will be held at the close of the conference, at 2:00 p.m. on Wednesday, March 23.

Many women and their doctors are concerned about the use of menopausal hormone therapy (MHT) for their menopausal symptoms and interested in learning about alternatives. For many decades, using estrogen (or, in a woman with a uterus, using a combination of estrogen and a progestin) has been the therapy of choice for relieving menopause-related symptoms. But recently, some large clinical trials have found a greater chance of serious health problems such as blood clots, stroke, heart disease, or breast cancer and benefits like fewer hip fractures or less risk of colon cancer in certain groups of women using MHT. It is not clear how these findings apply to women with symptoms because these clinical trials were not designed to study such women, but rather to test whether MHT could prevent chronic diseases or conditions of aging, such as heart disease or cognitive decline.

Research has identified a number of hormonal and non-hormonal approaches that show promise for managing menopause-related symptoms. A careful examination of these strategies for symptom management is urgently needed to provide women and their health care providers with options that will best control their symptoms and restore their quality of life.

The conference presentations and discussions will focus on the following five key questions:

  • What is the evidence that the symptoms more frequently reported by middle-aged women are attributable t
    '"/>


  • Contact: Kelli Marciel
    marcielk@od.nih.gov
    301-496-4819
    NIH/Office of the Director
    16-Mar-2005


    Page: 1 2

    Related biology news :

    1. AFCYBER holds science and technology symposium
    2. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
    3. Detecting transmissibility of avian influenza virus in human households
    4. New research holds promise for protecting cancer patients against infertility
    5. Canadian paper innovation holds promise for improved global health safety
    6. Honey bee genome holds clues to social behavior
    7. Research holds promise for herpes vaccine
    8. The first tree genome is published: Poplar holds promise as renewable bioenergy resource
    9. Receptor holds the key to mosquito immune response
    10. North Poles ancient past holds lessons for future global warming
    11. NIH holds state-of-the-science conference on multivitamin/mineral supplements, May 15 - 17, 2006

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:5/30/2020)... ... May 29, 2020 , ... eInfochips, a leading provider of ... with EchoNous Inc. to develop the cloud-based connected health KOSMOS platform that has ... has been clinically tested versus expert measurements, yielding improved results in precision and ...
    (Date:5/26/2020)... ... May 26, 2020 , ... ... for biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology ... T cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ® ...
    (Date:5/21/2020)... ... ... Law Enforcement has always been a highly stressful career – serving to protect, ... and women put them constantly in harm’s way both from the criminal element as ... to face very high daily stress. Now, COVID-19 introduces another even greater degree of ...
    Breaking Biology News(10 mins):
    (Date:5/14/2020)... , ... May 12, 2020 , ... ... for translational research, is bringing together thousands of industry leaders, clinicians, research scientists, ... highlights two plenary speakers, Carl June, MD, Director of the Center for Cellular ...
    (Date:5/5/2020)... ... 05, 2020 , ... ProductLife Group has marked the next phase ... group after 13 years at Altran, where he was Group VP of Life Sciences ... being a Pharmacist, Xavier was involved in his early career in the development of ...
    (Date:4/22/2020)... (PRWEB) , ... April 20, 2020 , ... ... offices in Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila ... of Omixon’s flagship product Holotype HLA since 2014 before stepping into the CEO ...
    (Date:4/7/2020)... ... April 06, 2020 , ... Red Nucleus, a ... industry, has announced the release of at-home virtual learning resources for all client ... health and safety of our employees as we continue to implement measures to ...
    Breaking Biology Technology:
    Cached News: